Project Grant R41AG087866
Award Date
9/25/24
Completion Date
8/31/25
Dollars Obligated
$473K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92126, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $885,006 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Brigham & Women's Hospital Inc. to develop a smartphone-based point-of-care diagnostic system to detect Alzheimer's disease-related biomarkers (amyloid-beta, phosphorylated tau, and neurofilament light chain) in blood plasma within 30 minutes. The goal is to create an affordable, user-friendly, and accurate blood test that can be used in primary care settings...
The National Institute on Aging awarded a $514,862 Project Grant (CFDA 93.866 - Aging Research) to Neuroindx, a for-profit, woman-owned small business, to develop an on-chip functional assay for identifying candidate microtubule-binding drugs to treat Alzheimer's Disease and related disorders (ADRDs). The grant supports the creation of an in vitro model system that can replicate key features of the neuronal microtubule microenvironment and use kinesin-based readouts to measure the ability of...
The National Institute on Aging (NIA) awarded a $245,148 project grant under its Aging Research Federal Grant Program (CFDA 93.866) to Eyenexo LLC, a for-profit small business located in Boston, MA. The project aims to develop an automated rodent behavior testing system for non-invasively assessing early Alzheimer's disease (AD). The system will leverage computer vision technology to track and analyze defensive behaviors, such as freezing and escape responses, triggered by looming visual...
The National Institute on Aging (NIA) has awarded Neucyte Inc., a minority-owned small business, a $500,000 Project Grant under the Aging Research federal grant program (CFDA 93.866) to develop an innovative microphysiological systems (MPS) platform for high-throughput screening of potential Alzheimer's disease (AD) and AD-related dementia (ADRD) therapeutics. The project aims to create a "mini-brain assembled organoids" (assembloids) platform using AD patient-derived and gene-edited...
The National Institute on Aging (NIA) awarded a $1,783,700.00 Project Grant under the Aging Research program (CFDA 93.866) to the University of Illinois to develop novel blood-brain barrier permeable multimodal imaging agents for the diagnosis of neurodegenerative diseases, with a focus on Alzheimer's disease and related dementias. The 3-year grant aims to employ organic and inorganic chemical design principles to generate diagnostic agents capable of detecting protein aggregation,...
This $306,509 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Captis Diagnostics Inc. aims to develop a technology platform for rapid magnetic isolation of neuronal extracellular vesicles (EVs) from blood plasma samples. The goal is to enable the detection of biomarkers for neurological diseases such as Alzheimer's, Parkinson's, and traumatic brain injury through a minimally invasive liquid biopsy approach. Key activities include developing...
The Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $307,538 to Sage Cerebrovascular Diagnostics, Inc. to develop and validate a novel, minimally invasive diagnostic assay to discriminate Alzheimer's disease from vascular dementia. The goal is to create a sensitive and specific biomarker test to improve detection and stratification of individuals with cognitive impairment due to vascular damage to the brain. The proposed...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $509,038 to Ceiba Bio Inc. to develop a blood-based exercise mimetic as a potential treatment for Alzheimer's disease and related dementias. The project aims to identify lead recombinant human GPLD1 molecules, conduct in vivo pharmacokinetic profiling, and test the disease-modifying effects of GPLD1 in an Alzheimer's mouse model. Successful completion of these aims is expected to advance the...
The National Institute on Aging (NIA) awarded a $107,948 Project Grant under the Aging Research federal grant program (CFDA 93.866) to The Research Foundation For The State University Of New York (The Research Foundation) to conduct research into advancing Alzheimer's disease diagnosis through MRI-based predictive modeling of Alzheimer's disease molecular subtypes. The goal is to enhance understanding of the biological signatures that distinguish subgroups of Alzheimer's patients using a...
The federal Project Grant award R21AG090974, totaling $437,875.00, was provided by the National Institute on Aging (CFDA 93.866 Aging Research) to the University of California, San Diego (UCSD) to quantify the lifetimes of neurovascular proteins in health, aging, and Alzheimer's disease. The key objectives are to: Generate a comprehensive atlas of neurovascular protein lifetimes in healthy, aging, and Alzheimer's disease models using stable isotope labeling and mass spectrometry proteomics....